Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn

Company News Summary

Virtus Health Provides Update on COVID-19 Impact

21 Apr 2020  |  16:06:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: COVID-19 Impact Update - VRT resumes IVF Treatment

Virtus Health supported decision of 21 April 2020 by the Australian Federal Government to lift the suspension on elective surgery, including Assisted Reproductive Services and confirmed that it has introduced COVID-19 testing for patients. The clinics in Australia will resume fertility services and ARS treatment from 27 April with increased infection control and safety protocols. Throughout the elective surgery suspension, diagnostic and pathology services maintained testing and screening services at reduced capacity. Diagnostics will begin to increase staffing and services as ARS operations return to normal levels and demand for diagnostics rises. The Company's Singapore clinic, the Virtus Fertility Centre, has remained open. All clinics in Ireland and the United Kingdom remain closed.

Please click here for full details

See more ASX300 News Announcements